These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1668765)

  • 1. Natural killer cell activity following cryosurgery of normal and tumour bearing liver in an animal model.
    Bayjoo P; Rees RC; Goepel JR; Jacob G
    J Clin Lab Immunol; 1991 Jul; 35(3):129-32. PubMed ID: 1668765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural killer activity of splenocytes of C3HA mice in the early period after transplantation of hepatoma 22a cells].
    Filatova NA; Malygin AM; Pleskach VA; Fel' VIa
    Eksp Onkol; 1987; 9(6):52-5. PubMed ID: 3436291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of hepatocellular function on NK and T cell tumoricidal activity.
    Roughneen PT; Kulkarni S; Kumar SC; Kulkarni AD; Fanslow W; Pellis NR; Rowlands BJ
    Surgery; 1988 Nov; 104(5):888-93. PubMed ID: 2973140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Animal experiment studies of cryosurgical treatment of DS sarcomas and Morris hepatomas implanted in the liver].
    Ernst M; Bauknecht KJ; Hartmann CA; Herter M; Häring R; Dressler S
    Zentralbl Chir; 1988; 113(17):1111-5. PubMed ID: 3188704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma.
    Schmitz V; Barajas M; Wang L; Peng D; Duarte M; Prieto J; Qian C
    Hepatology; 2001 Jul; 34(1):72-81. PubMed ID: 11431736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of natural killer and lymphocyte functions associated with carcinogen-induced premalignant hyperplastic nodules in rat liver.
    Leu RW; Norton TR; Herriott MJ; Ringer DP; Kearns RJ
    Cancer Res; 1985 Jul; 45(7):3282-7. PubMed ID: 2860970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adhesive glycoprotein from rat ascites hepatoma cells potentiates natural cytotoxic activity by rat spleen cells.
    Chen JY; Kurano R; Hirashima M; Hayashi H
    Immunology; 1986 May; 58(1):95-100. PubMed ID: 3710521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T; Seemayer TA; Lapp WS
    Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer lymphocytes in rat liver sinusoidal blood.
    Lukomska B; Ruffa T; Olszewski L; Engeset A
    Lymphology; 1983 Dec; 16(4):202-8. PubMed ID: 6664113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective NK cell activity following thermal injury.
    Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
    Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble glucan and lymphokine-activated killer (LAK) cells in the therapy of experimental hepatic metastases.
    Sherwood ER; Williams DL; McNamee RB; Jones EL; Browder IW; Di Luzio NR
    J Biol Response Mod; 1988 Apr; 7(2):185-98. PubMed ID: 3283299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant drugs increase natural killer cell activity in lung cancer.
    Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
    Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
    Vujanovic NL; Herberman RB; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on augmentation of local antitumor immunity in liver by interleukin-2 gene transfer via portal vein: a possible explanation for contradictory in vivo and vitro results of interleukin-2 treatment in a rat model of colon carcinoma metastasis.
    Vermijlen D; Timmers M; Wisse E
    Cancer Gene Ther; 2003 May; 10(5):432-3. PubMed ID: 12719713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.